Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01929694
Other study ID # 9B2
Secondary ID
Status Completed
Phase Phase 4
First received August 19, 2013
Last updated October 2, 2014
Start date September 2013
Est. completion date April 2014

Study information

Verified date October 2014
Source Northumbria University
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Brain, Performance and Nutrition Research Centre, Northumbria University
Study type Interventional

Clinical Trial Summary

Consuming a guaraná and vitamin and mineral complex can improve mental fatigue and cognitive function at rest; guaraná also contains caffeine, which can reduce perceived exertion and increase fat burning during exercise. The purpose of this study is to test whether consuming a guaraná and vitamin and mineral product before exercise influences affect (mood), physical exertion and fat burning during exercise and mental fatigue, cognitive performance and affect post-exercise.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 2014
Est. primary completion date April 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

Individuals must be:

- Healthy

- Male

- Aged between 18 and 35years

- Habitually active (exercising at least twice a week)

- Able to run at a moderate pace for 30 minutes non-stop on a treadmill

Exclusion Criteria:

Individuals will not be eligible to take part in this study if they:

- have a history of neurological or psychiatric diseases excluding anxiety or depression

- have a current diagnosis of depression or anxiety

- have a history of significant head trauma, metabolic, endocrine or cardiac disorders

- have smoked within the last 3 months,

- have high blood pressure >140/90mmHg

- consume > 500 mg caffeine per day from all dietary sources

- have adverse reactions to caffeine containing products (i.e. tea, coffee, energy drinks, cola, Pepsi)

- are currently taking any pharmaceuticals

- have habitual taken dietary supplements within the last 4 weeks (defined as =3 consecutive days or =4 days in total per week)

- have current or history of drug or alcohol abuse

- have participated in another clinical trial within 30 days prior to screening

- have any condition which may interfere with your ability to perform assessments

- have any history of hypersensitivity to the investigational product or its active or inactive constituents or any food allergy or intolerance

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Affect and Exertion During and Post-exercise

Intervention

Dietary Supplement:
Berocca Boost

Placebo


Locations

Country Name City State
United Kingdom Brain, Performance and Nutrition Research Centre, Northumbria Univerity Newcastle upon Tyne Tyne and Wear

Sponsors (2)

Lead Sponsor Collaborator
Northumbria University Bayer

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Cognitive Function Participants will complete a set of cognitive tasks (Immediate Word Recall, Choice Reaction Time, Rapid visual information processing task, Numeric Working Memory, Delayed word Recall, Word Recognition and Picture Recognition) measuring episodic memory, working memory, attention and decision making. Assessed at baseline, pre-exercise and immeadiately and 75min post-exercise No
Other Mood Assessed using the Bond-Lader Visual Analogue Scales (VAS) and Energy VAS (concentration, physical stamina, mental stamina) Assessed at baseline, pre-exercise and immeadiately and 75min post-exercise No
Other Substrate Metabolism Measured using an online gas analysis system (Cortex). Oxygen uptake, carbon dioxide production, fat and carbohydrate oxidation and energy expenditure will be measured for 1 min at each 10min interval. Measured at 10min intervals during exercise No
Primary Affect Affect measured using the Feeling Scale and Felt Arousal Scale Assessed pre-exercise, at 10min intervals during exercise and 45 and 75min post-exercise No
Secondary Exertion Rate of perceived exertion measured using the Borg scale Measured at 10min intervals during exercise No